Cargando…

OLA1 promotes colorectal cancer tumorigenesis by activation of HIF1α/CA9 axis

BACKGROUND: Obg-like ATPase 1 (OLA1) is a highly conserved GTPase, which was over expressed in a variety of malignant tumors, but its role in colorectal cancer (CRC) was poorly studied. PATIENTS AND METHODS: Three public CRC gene databases were applied for OLA1 mRNA expression detection. The clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yue, Kong, Xiang-Xing, He, Jin-Jie, Xu, Yan-Bo, Zhang, Jian-Kun, Zou, Lu-Yang, Ding, Ke-Feng, Xu, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020043/
https://www.ncbi.nlm.nih.gov/pubmed/35440019
http://dx.doi.org/10.1186/s12885-022-09508-1
_version_ 1784689444151885824
author Liu, Yue
Kong, Xiang-Xing
He, Jin-Jie
Xu, Yan-Bo
Zhang, Jian-Kun
Zou, Lu-Yang
Ding, Ke-Feng
Xu, Dong
author_facet Liu, Yue
Kong, Xiang-Xing
He, Jin-Jie
Xu, Yan-Bo
Zhang, Jian-Kun
Zou, Lu-Yang
Ding, Ke-Feng
Xu, Dong
author_sort Liu, Yue
collection PubMed
description BACKGROUND: Obg-like ATPase 1 (OLA1) is a highly conserved GTPase, which was over expressed in a variety of malignant tumors, but its role in colorectal cancer (CRC) was poorly studied. PATIENTS AND METHODS: Three public CRC gene databases were applied for OLA1 mRNA expression detection. The clinical data of 111 CRC patients were retrospectively collected from the Second Affiliated Hospital of Zhejiang University (SAHZU) for OLA1 protein expression and Kaplan-Meier Survival analysis. OLA1 stably knocked out CRC cell lines were conducted by CRISPR-Cas9 for experiments in vitro and in vivo. RESULTS: OLA1 was highly expressed in 84% CRC compared to matched surrounding tissues. Patients with OLA1 high expression had a significantly lower 5-year survival rate (47%) than those with OLA1 low expression (75%). OLA1 high expression was an independent factor of poor prognosis in CRC patients. OLA1-KO CRC cell lines showed lower ability of growth and tumorigenesis in vitro and in vivo. By mRNA sequence analysis, we found 113 differential express genes in OLA1-KO cell lines, of which 63 were hypoxic related. HIF1α was a key molecule in hypoxic regulation. Further molecular mechanisms showed HIF1α /CA9 mRNA and/or protein levels were heavily downregulated in OLA1-KO cell lines, which could explain the impaired tumorigenesis. According to previous studies, HIF1α was a downstream gene of GSK3β, we verified GSK3β was over-activated in OLA1-KO cell lines. CONCLUSION: OLA1 was a new gene that was associated with carcinogenesis and poor outcomes in CRC by activation of HIF1α/CA9 axis, which may be interpreted by GSK3β. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09508-1.
format Online
Article
Text
id pubmed-9020043
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-90200432022-04-21 OLA1 promotes colorectal cancer tumorigenesis by activation of HIF1α/CA9 axis Liu, Yue Kong, Xiang-Xing He, Jin-Jie Xu, Yan-Bo Zhang, Jian-Kun Zou, Lu-Yang Ding, Ke-Feng Xu, Dong BMC Cancer Research BACKGROUND: Obg-like ATPase 1 (OLA1) is a highly conserved GTPase, which was over expressed in a variety of malignant tumors, but its role in colorectal cancer (CRC) was poorly studied. PATIENTS AND METHODS: Three public CRC gene databases were applied for OLA1 mRNA expression detection. The clinical data of 111 CRC patients were retrospectively collected from the Second Affiliated Hospital of Zhejiang University (SAHZU) for OLA1 protein expression and Kaplan-Meier Survival analysis. OLA1 stably knocked out CRC cell lines were conducted by CRISPR-Cas9 for experiments in vitro and in vivo. RESULTS: OLA1 was highly expressed in 84% CRC compared to matched surrounding tissues. Patients with OLA1 high expression had a significantly lower 5-year survival rate (47%) than those with OLA1 low expression (75%). OLA1 high expression was an independent factor of poor prognosis in CRC patients. OLA1-KO CRC cell lines showed lower ability of growth and tumorigenesis in vitro and in vivo. By mRNA sequence analysis, we found 113 differential express genes in OLA1-KO cell lines, of which 63 were hypoxic related. HIF1α was a key molecule in hypoxic regulation. Further molecular mechanisms showed HIF1α /CA9 mRNA and/or protein levels were heavily downregulated in OLA1-KO cell lines, which could explain the impaired tumorigenesis. According to previous studies, HIF1α was a downstream gene of GSK3β, we verified GSK3β was over-activated in OLA1-KO cell lines. CONCLUSION: OLA1 was a new gene that was associated with carcinogenesis and poor outcomes in CRC by activation of HIF1α/CA9 axis, which may be interpreted by GSK3β. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-09508-1. BioMed Central 2022-04-19 /pmc/articles/PMC9020043/ /pubmed/35440019 http://dx.doi.org/10.1186/s12885-022-09508-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Liu, Yue
Kong, Xiang-Xing
He, Jin-Jie
Xu, Yan-Bo
Zhang, Jian-Kun
Zou, Lu-Yang
Ding, Ke-Feng
Xu, Dong
OLA1 promotes colorectal cancer tumorigenesis by activation of HIF1α/CA9 axis
title OLA1 promotes colorectal cancer tumorigenesis by activation of HIF1α/CA9 axis
title_full OLA1 promotes colorectal cancer tumorigenesis by activation of HIF1α/CA9 axis
title_fullStr OLA1 promotes colorectal cancer tumorigenesis by activation of HIF1α/CA9 axis
title_full_unstemmed OLA1 promotes colorectal cancer tumorigenesis by activation of HIF1α/CA9 axis
title_short OLA1 promotes colorectal cancer tumorigenesis by activation of HIF1α/CA9 axis
title_sort ola1 promotes colorectal cancer tumorigenesis by activation of hif1α/ca9 axis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020043/
https://www.ncbi.nlm.nih.gov/pubmed/35440019
http://dx.doi.org/10.1186/s12885-022-09508-1
work_keys_str_mv AT liuyue ola1promotescolorectalcancertumorigenesisbyactivationofhif1aca9axis
AT kongxiangxing ola1promotescolorectalcancertumorigenesisbyactivationofhif1aca9axis
AT hejinjie ola1promotescolorectalcancertumorigenesisbyactivationofhif1aca9axis
AT xuyanbo ola1promotescolorectalcancertumorigenesisbyactivationofhif1aca9axis
AT zhangjiankun ola1promotescolorectalcancertumorigenesisbyactivationofhif1aca9axis
AT zouluyang ola1promotescolorectalcancertumorigenesisbyactivationofhif1aca9axis
AT dingkefeng ola1promotescolorectalcancertumorigenesisbyactivationofhif1aca9axis
AT xudong ola1promotescolorectalcancertumorigenesisbyactivationofhif1aca9axis